Key Financial’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Key Financial's IBRX Position: Q3 2026 in Review
Key Financial held its ImmunityBio (IBRX) position steady in Q3 2026 at 2,000 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #720.
Key Financial first reported a position in IBRX in Q2 2025 and has held it in 6 quarters since. 326 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Key Financial held 2,000 shares of ImmunityBio worth $18.9K as of Q3 2026.
- Key Financial left its ImmunityBio share count unchanged in Q3 2026.
- ImmunityBio made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #720 holding.
- Key Financial first reported a position in ImmunityBio in Q2 2025 and has held it in 6 quarters since.
- 326 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.